|premium|

OCGN Stock Forecast: Ocugen Inc extends decline as it misses on third quarter earnings

  • NASDAQ:OCGN fell by 7.37% during Tuesday’s trading session.
  • Ocugen reported its third-quarter financial results on Tuesday.
  • Ocugen is targeting COVID-19 vaccinations for children.

NASDAQ:OCGN extended its recent skid and has now lost nearly 50% over the past five trading days. On Tuesday, shares dropped a further 7.37% and closed the trading session at $8.92. It has been a bumpy ride for Ocugen shareholders as of late, and on Tuesday a disappointing earnings report for the third quarter magnified its losses. Ocugen’s report came on a day full of high-profile companies reporting as well. Other companies like PayPal (NASDAQ:PYPL), Palantir (NYSE:PLTR), Coinbase (NASDAQ:COIN), and Nio (NYSE:NIO) all reported on Tuesday, so Ocugen was lost in the shuffle. Still, the stock has been on a steep downward trajectory over the past couple of weeks, despite numerous catalysts that could be interpreted as being positive for the future of the company.


Stay up to speed with hot stocks' news!


As mentioned earlier, Ocugen reported its third-quarter financial results, narrowly missing Wall Street expectations. Ocugen saw a loss of $10.8 million and earnings per share of a loss of $0.05. This was a wider loss than expected by analysts who were forecasting a loss of $0.04 per share for the quarter. The earnings miss only proved to add to Ocugen’s recent struggles, as the stock continued to sell-off.

OCGN stock price

OCGN

Ocugen did report some potential catalysts as the company heads into 2022, including focussing on children for its COVID-19 vaccine candidate: Covaxin. Ocugen generally operates in North America, where vaccines from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) have dominated usage. Now that the US and Canada are both looking towards vaccinating children, Ocugen is eyeing this as an opportunity to gain an important market share for its vaccine.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

More from Stocks Reporter
Share:

Editor's Picks

EUR/USD looks apathetic around 1.1770

EUR/USD comes under renewed pressure on Tuesday, deflating below the 1.1800 support and reversing two consecutive days of gains. The pair’s decline follows the persistent move higher in the US Dollar, as trade uncertainty dominates the sentiment ahead of President Trump’s SOTU speech.

GBP/USD regains 1.3500 and above

GBP/USD extends its advance for the third day in a row on Tuesday, this time retesting the area beyond the 1.3500 hurdle. Cable’s uptick comes despite decent gains in the Greenback and the dovish message from the BoE’s Bailey at the UK Parliament.

Gold appears offered around $5,150

Gold is giving back a good portion of the recent multi-day rally, receding to the $5,150 zone per troy ounce amid the decent bounce in the US Dollar and mixed US Treasuty yields. In the meantime, markets’ attention remain on upcoming comments from Fed speakers.

Ripple’s DeFi shift in focus: Navigating XRPL EVM sidechain growth, XRPFi migration and liquidity

Ripple (XRP) has continued to trade under pressure, extending its decline by approximately 63% from the record high of $3.66 in July. The remittance token is trading above support at $1.35, while its upside appears limited by key supply zones, starting with $1.40, at the time of writing on Tuesday.

The Citrini report: How a debatable AI narrative can shake Wall Street

That AI-related headline alone was enough to rattle investors.US stocks slid sharply on Monday after a widely circulated Citrini Research memo outlined a hypothetical “2028 Global Intelligence Crisis”, warning that rapid AI adoption could push US unemployment into double digits as early as by mid-2028.

XRP pressured by weak ETF flows and declining retail interest

Ripple (XRP) is edging lower, trading above its intraday low of $1.32 at the time of writing on Tuesday. The decline from its weekly opening of $1.39 reflects heightened volatility in the broader cryptocurrency market, accentuated by tariff-triggered uncertainty.